Loading
Latest filing published 16 Jan 2024 for 天坛生物, €32k.
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
付道兴 (board member) discloses dealings in 天坛生物 to SSE / SZSE (CSRC). We count 2 filings; the first trade dates from 4 September 2023 and the latest from 16 January 2024.
Purchases make up the whole of the open-market record (2 purchases, €65k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. So far in 2024, the count stands at 1 purchase and no sales.
Most recently, on 16 January 2024, the filings show an open-market purchase worth €32k in 天坛生物. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.